---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-22-004137"
form_type: "8-K"
ticker: "ENTXW"
cik: "0001638097"
company_name: "Entera Bio Ltd."
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:26:12.900740+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Entera Bio receives Nasdaq delinquency notice for minimum bid price non-compliance

## Summary
- Nasdaq notified Entera Bio on Nov 21, 2022 that ordinary shares fail minimum $1.00 bid price for 30 consecutive business days.
- Company has 180 calendar days, until May 22, 2023, to regain compliance with minimum bid price requirement.
- To cure, closing bid must be at least $1.00 for a minimum of 10 consecutive business days before deadline.
- If non-compliant by May 22, 2023, Entera may seek an additional 180-day period subject to meeting other listing standards.
- Notice has no immediate effect on the company's business operations.

## SEC filing metadata
- accession: 0001178913-22-004137
- form_type: 8-K
- ticker: ENTXW
- cik: 0001638097
- company_name: Entera Bio Ltd.
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638097/000117891322004137/0001178913-22-004137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638097/000117891322004137/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-22-004137
- JSON: https://secwatch.observer/filing/0001178913-22-004137.json
- Plain text: https://secwatch.observer/filing/0001178913-22-004137.txt

## Key facts
- Listing & Compliance Notices
  Entera Bio Ltd. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: November 21, 2022, Entera Bio Ltd., a company organized under the laws of the State of Israel (the “ Company ”), received a notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company’s ordinary shares, par value of NIS 0.0000769 per share (the “ ordinary shares ”), fail to comply with the $1.00 minimum bid price requirement for continued listing on Nasdaq in accordance with Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the ordinary shares for the 30 consecutive business days prior to the date of the Notice. Pursuant to Nasdaq Listing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638097/000117891322004137/0001178913-22-004137-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.